Q: You noted that Cipher "is in a bit of a proxy battle and we like John Mull, a 37% owner trying to improve the company." But isn't Mr. Mull effectively seeking to take control of the company - which presents the risk of it being taken private at no significant premium to shareholders?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Have held this for 2 years and down %50. Comments on their latest quarter and is it worth keeping.
-
BioSyent Inc. (RX $15.25)
-
CRH Medical Corporation (CRH $4.99)
-
Merus Labs International Inc. (MSL $1.65)
-
Cipher Pharmaceuticals Inc. (CPH $18.65)
Q: If you have to rank them from fundamental perspective, which names would you prefer? Which ones could be potential takeover candidates?
Q: What is happening with the Board of Directors with this Company? Thanks.
Q: Appreciate your thoughts on Cipher which has been extremely frustrating to hold. Do you think price can appreciate if and when the sector sentiment improves?
Q: Could you comment on Cipher's Q1 results?
Q: WHAT IS YOUR VIEW ABOUT THIS CO. GOING FORWARD.